Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma.
BACKGROUND: The Hedgehog (HH) signaling pathway is critical for embryonic development and adult homeostasis. Recent studies have identified regulatory roles for this pathway in certain cancers with mutations in the HH pathway genes. The extent to which mutations of the HH pathway genes are involved...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3691204?pdf=render |
id |
doaj-8fb1acf1b01742ddb64b80e1669bc29c |
---|---|
record_format |
Article |
spelling |
doaj-8fb1acf1b01742ddb64b80e1669bc29c2020-11-25T01:56:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0186e6668510.1371/journal.pone.0066685Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma.Chuan Bian LimCecilia M PrêleHui Min CheahYuen Yee ChengSonja KlebeGlen ReidD Neil WatkinsSvetlana BalticPhilip J ThompsonSteven E MutsaersBACKGROUND: The Hedgehog (HH) signaling pathway is critical for embryonic development and adult homeostasis. Recent studies have identified regulatory roles for this pathway in certain cancers with mutations in the HH pathway genes. The extent to which mutations of the HH pathway genes are involved in the pathogenesis of malignant mesothelioma (MMe) is unknown. METHODOLOGY/PRINCIPAL FINDINGS: Real-time PCR analysis of HH pathway genes PTCH1, GLI1 and GLI2 were performed on 7 human MMe cell lines. Exon sequencing of 13 HH pathway genes was also performed in cell lines and human MMe tumors. In silico programs were used to predict the likelihood that an amino-acid substitution would have a functional effect. GLI1, GLI2 and PTCH1 were highly expressed in MMe cells, indicative of active HH signaling. PTCH1, SMO and SUFU mutations were found in 2 of 11 MMe cell lines examined. A non-synonymous missense SUFU mutation (p.T411M) was identified in LO68 cells. In silico characterization of the SUFU mutant suggested that the p.T411M mutation might alter protein function. However, we were unable to demonstrate any functional effect of this mutation on Gli activity. Deletion of exons of the PTCH1 gene was found in JU77 cells, resulting in loss of one of two extracellular loops implicated in HH ligand binding and the intracellular C-terminal domain. A 3-bp insertion (69_70insCTG) in SMO, predicting an additional leucine residue in the signal peptide segment of SMO protein was also identified in LO68 cells and a MMe tumour. CONCLUSIONS/SIGNIFICANCE: We identified the first novel mutations in PTCH1, SUFU and SMO associated with MMe. Although HH pathway mutations are relatively rare in MMe, these data suggest a possible role for dysfunctional HH pathway in the pathogenesis of a subgroup of MMe and help rationalize the exploration of HH pathway inhibitors for MMe therapy.http://europepmc.org/articles/PMC3691204?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Chuan Bian Lim Cecilia M Prêle Hui Min Cheah Yuen Yee Cheng Sonja Klebe Glen Reid D Neil Watkins Svetlana Baltic Philip J Thompson Steven E Mutsaers |
spellingShingle |
Chuan Bian Lim Cecilia M Prêle Hui Min Cheah Yuen Yee Cheng Sonja Klebe Glen Reid D Neil Watkins Svetlana Baltic Philip J Thompson Steven E Mutsaers Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. PLoS ONE |
author_facet |
Chuan Bian Lim Cecilia M Prêle Hui Min Cheah Yuen Yee Cheng Sonja Klebe Glen Reid D Neil Watkins Svetlana Baltic Philip J Thompson Steven E Mutsaers |
author_sort |
Chuan Bian Lim |
title |
Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. |
title_short |
Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. |
title_full |
Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. |
title_fullStr |
Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. |
title_full_unstemmed |
Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. |
title_sort |
mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
BACKGROUND: The Hedgehog (HH) signaling pathway is critical for embryonic development and adult homeostasis. Recent studies have identified regulatory roles for this pathway in certain cancers with mutations in the HH pathway genes. The extent to which mutations of the HH pathway genes are involved in the pathogenesis of malignant mesothelioma (MMe) is unknown. METHODOLOGY/PRINCIPAL FINDINGS: Real-time PCR analysis of HH pathway genes PTCH1, GLI1 and GLI2 were performed on 7 human MMe cell lines. Exon sequencing of 13 HH pathway genes was also performed in cell lines and human MMe tumors. In silico programs were used to predict the likelihood that an amino-acid substitution would have a functional effect. GLI1, GLI2 and PTCH1 were highly expressed in MMe cells, indicative of active HH signaling. PTCH1, SMO and SUFU mutations were found in 2 of 11 MMe cell lines examined. A non-synonymous missense SUFU mutation (p.T411M) was identified in LO68 cells. In silico characterization of the SUFU mutant suggested that the p.T411M mutation might alter protein function. However, we were unable to demonstrate any functional effect of this mutation on Gli activity. Deletion of exons of the PTCH1 gene was found in JU77 cells, resulting in loss of one of two extracellular loops implicated in HH ligand binding and the intracellular C-terminal domain. A 3-bp insertion (69_70insCTG) in SMO, predicting an additional leucine residue in the signal peptide segment of SMO protein was also identified in LO68 cells and a MMe tumour. CONCLUSIONS/SIGNIFICANCE: We identified the first novel mutations in PTCH1, SUFU and SMO associated with MMe. Although HH pathway mutations are relatively rare in MMe, these data suggest a possible role for dysfunctional HH pathway in the pathogenesis of a subgroup of MMe and help rationalize the exploration of HH pathway inhibitors for MMe therapy. |
url |
http://europepmc.org/articles/PMC3691204?pdf=render |
work_keys_str_mv |
AT chuanbianlim mutationalanalysisofhedgehogsignalingpathwaygenesinhumanmalignantmesothelioma AT ceciliamprele mutationalanalysisofhedgehogsignalingpathwaygenesinhumanmalignantmesothelioma AT huimincheah mutationalanalysisofhedgehogsignalingpathwaygenesinhumanmalignantmesothelioma AT yuenyeecheng mutationalanalysisofhedgehogsignalingpathwaygenesinhumanmalignantmesothelioma AT sonjaklebe mutationalanalysisofhedgehogsignalingpathwaygenesinhumanmalignantmesothelioma AT glenreid mutationalanalysisofhedgehogsignalingpathwaygenesinhumanmalignantmesothelioma AT dneilwatkins mutationalanalysisofhedgehogsignalingpathwaygenesinhumanmalignantmesothelioma AT svetlanabaltic mutationalanalysisofhedgehogsignalingpathwaygenesinhumanmalignantmesothelioma AT philipjthompson mutationalanalysisofhedgehogsignalingpathwaygenesinhumanmalignantmesothelioma AT stevenemutsaers mutationalanalysisofhedgehogsignalingpathwaygenesinhumanmalignantmesothelioma |
_version_ |
1724981970359812096 |